Aug 11 (Reuters) - Bristol-Myers Squibb (NYSE:BMY) Co BMY.N :
* HEALTH CANADA APPROVES OPDIVO® (NIVOLUMAB) PLUS YERVOY® (IPILIMUMAB) COMBINED WITH LIMITED CHEMOTHERAPY FOR THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER
Aug 11 (Reuters) - Bristol-Myers Squibb (NYSE:BMY) Co BMY.N :
* HEALTH CANADA APPROVES OPDIVO® (NIVOLUMAB) PLUS YERVOY® (IPILIMUMAB) COMBINED WITH LIMITED CHEMOTHERAPY FOR THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER